PMN310 is a humanized IgG1 monoclonal antibody that works by selectively targeting soluble amyloid-beta oligomers, which according to ProMIS are the most toxic and pathogenic form of amyloid-beta
According to the TCGA database, The expression levels of SLC7A11 mRNA in Cervical cancer (CESC), Cholangiocarcinoma (CHOL), Colonic adenocarcinoma (COAD), Esophagus cancer (ESCA), Head and neck squamous cell carcinoma (HNSC), chromophobe kidney cell carcinoma (KICH), Clear cell carcinoma of kidney (KIRC), Papillary cell carcinoma of the kidney (KIRP), Liver cell carcinoma (LIHC), Lung adenocarcinoma (LUAD), Squamous cell carcinoma of the lung (LUSC), Adenocarcinoma of the pancreas (PAAD), Rectum adenocarcinoma (READ), Sarcoma (SARC), Cutaneous melanoma (SKCM), Stomach adenocarcinoma (STAD), and Endometrial carcinoma of the flesh (UCEC) were significantly higher than those in adjacent normal tissues
Strongly recommend
2021;21:e32731
PubMed, Cochrane Library, Embase, Web of Science, and Chinese databases were searched from inception to 2 October 2024
Recommended for anyone